BEIJING, Oct. 24 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced the following investor events:
Event Date Location
UBS China Life Sciences Conference November 8-9, 2007 Shanghai, China
2007
Goldman Sachs China Investment November 12-13, 2007 Beijing, China
Frontier Conference 2007
Credit Suisse Phoenix Health Care November 13-14, 2007 Phoenix, US
Conference
Credit Suisse China Healthcare November 15-23, 2007 New York, Boston,
Sector Global Roadshow London,
Hong Kong and
Singapore
China Medical Technologies’ management team will discuss at these events the Company’s strategies, operations and growth opportunities, as well as its published results to date with securities analysts and institutional investors.
Please contact UBS, Goldman Sachs and Credit Suisse for event details.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
China Medical Technologies, Inc.
Winnie Fan
Tel: +86-10-6530-8833
Email: IR@chinameditech.com
